Peritoneal Cancer
📧 Sign up to get email alerts when something new happens for Peritoneal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-08-03Clinical Trial Update: Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3) [Phase 3]
Phase 3 trial (ARIEL3) evaluating rucaparib as switch maintenance after platinum in relapsed high-grade serous or endometrioid ovarian cance…
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients [Phase 1]
Phase 1 study evaluating docetaxel in combination with PTK787 in metastatic breast cancer and gynecologic cancers; the trial conducted by Da…
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: Phase 1 Study of NY-ESO-1 Overlapping Peptides in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
Phase 1 study evaluating NY-ESO-1 overlapping peptides in epithelial ovarian, fallopian tube, or primary peritoneal cancer completed with re…
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Negative Pressure Therapy in Preventing Infection After Surgery in Patients With Colon, Rectal, Pancreatic, or Peritoneal Surface Cancer [NA]
This entry notes the completion of a clinical trial evaluating negative pressure therapy to prevent postoperative infection after surgery in…
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal Cancer [Phase 2]
A Phase 2 trial of CRLX101 in combination with Bevacizumab for recurrent ovarian, fallopian tube, or primary peritoneal cancer has completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab with or without everolimus in recurrent ovarian epithelial cancer, fallopian tube cancer, or primary pe…
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer [Phase 2]
Phase 2 trial update of alisertib (MLN8237) in ovarian, fallopian tube, or peritoneal cancer following a prior MLN8237 plus paclitaxel Phase…
-
CLINICAL_TRIALS trial_result · 2018-05-25Clinical Trial Update: Evaluation of Metformin, Targeting Cancer Stem Cells for Prevention of Relapse in Gynecologic Patients [Phase 2]
Phase 2 trial evaluating metformin for preventing relapse by targeting cancer stem cells in gynecologic cancers; results were posted in 2018…
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
A completed clinical trial update from the Gynecologic Oncology Group examining biomarkers in patients with previously untreated invasive ov…
-
CLINICAL_TRIALS trial_result · 2018-05-22Clinical Trial Update: YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy
A terminated clinical trial update investigating the serum biomarker YKL-40 in patients with newly diagnosed stage III-IV ovarian epithelial…
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 3]
This Phase 3 trial investigated bevacizumab with intravenous or intraperitoneal chemotherapy in stage II-III ovarian epithelial cancer, fall…
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 3]
Phase 3 trial update investigating bevacizumab with intravenous or intraperitoneal chemotherapy in stage II-III ovarian epithelial cancer, f…
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab [NA]
This is a completed clinical trial evaluating Polyvalent Vaccine-KLH Conjugate and Opt-821 in combination with Bevacizumab for fallopian tub…
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: p53MVA Vaccine and Gemcitabine Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer [Phase 1]
Phase 1 clinical trial update evaluating the p53MVA vaccine in combination with gemcitabine hydrochloride for recurrent ovarian epithelial c…
-
CLINICAL_TRIALS trial_result · 2018-04-19Clinical Trial Update: A Study of Chemotherapy Treatment for Patients With Ovarian Cancer [Phase 2]
This completed Phase 2 clinical trial evaluated a chemotherapy treatment for ovarian cancer and related fallopian tube and primary peritonea…
-
CLINICAL_TRIALS trial_result · 2018-04-12Clinical Trial Update: Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
A completed Gynecologic Oncology Group trial evaluated changes in brain function (cognitive side effects) in patients with stage I–IV ovaria…
-
CLINICAL_TRIALS trial_result · 2018-04-12Clinical Trial Update: Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer [NA]
A terminated clinical trial evaluated a triple antiemetic regimen (granisetron, aprepitant, and dexamethasone) to prevent chemotherapy-induc…
-
CLINICAL_TRIALS trial_result · 2018-04-12Clinical Trial Update: Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of topotecan for recurrent ovarian epithelial cancer or primary peritoneal cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-03-27Clinical Trial Update: MLN8237 for Treatment of Participants With Ovarian, Fallopian Tube, or Peritoneal Carcinoma [Phase 2]
Phase 2 trial update for MLN8237 in ovarian, fallopian tube, or peritoneal carcinoma; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix [Phase 2]
Phase 2 trial evaluating surgery with either oxaliplatin or mitomycin C for appendiceal tumors and primary peritoneal cancer; the study comp…
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update for a vaccine therapy in epithelial ovarian, fallopian tube, or peritoneal cancer has completed recruitment wi…
-
CLINICAL_TRIALS trial_result · 2018-03-12Clinical Trial Update: Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas [Phase 2, Phase 3]
This clinical trial update reports the completion of Phase 2 and Phase 3 testing evaluating drug sensitivity in ovarian, fallopian tube, and…
-
CLINICAL_TRIALS trial_result · 2018-02-19Clinical Trial Update: Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
Phase 3 trial evaluating diet and physical activity changes versus usual care for improving progression-free survival in previously treated …
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [Phase 3]
Phase 3 clinical trial evaluating Paclitaxel and Carboplatin with or without Bevacizumab in Stage II-IV ovarian epithelial cancer, primary p…
-
CLINICAL_TRIALS trial_result · 2018-01-19Clinical Trial Update: Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating carboplatin/pralatrexate in recurrent platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer co…